These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7065481)

  • 1. Oral theophylline disposition in cystic fibrosis.
    Georgitis JW; Eigen H; Warner R; Gonzales MA
    Ann Allergy; 1982 Mar; 48(3):175-7. PubMed ID: 7065481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of theophylline and bioavailability of a sustained release theophylline preparation in patients with cystic fibrosis.
    Valet SB; Schwartz RH; Brooks JG
    Ann Allergy; 1983 Mar; 50(3):161-5. PubMed ID: 6829982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics of oral theophylline. Comparison between asthmatic and cystic fibrosis patients].
    Repetto T; Marianelli L; Valenza T; Rosselli P; Messori A
    Pediatr Med Chir; 1985; 7(6):823-5. PubMed ID: 3837249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Montelukast pharmacokinetics in cystic fibrosis.
    Graff GR; Weber A; Wessler-Starman D; Smith AL
    J Pediatr; 2003 Jan; 142(1):53-6. PubMed ID: 12520255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The paradoxical effect of adrenergic and methylxanthine drugs in cystic fibrosis.
    Shapiro GG; Bamman J; Kanarek P; Bierman CW
    Pediatrics; 1976 Nov; 58(5):740-3. PubMed ID: 790287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theophylline disposition in cystic fibrosis.
    Isles A; Spino M; Tabachnik E; Levison H; Thiessen J; MacLeod S
    Am Rev Respir Dis; 1983 Apr; 127(4):417-21. PubMed ID: 6838048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probenecid pharmacokinetics in cystic fibrosis.
    Weber A; de Groot R; Ramsey B; Williams-Warren J; Smith A
    Dev Pharmacol Ther; 1991; 16(1):7-12. PubMed ID: 1879255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of amiloride after inhalation and oral administration in adolescents and adults with cystic fibrosis.
    Jones KM; Liao E; Hohneker K; Turpin S; Henry MM; Selinger K; Hsyu PH; Boucher RC; Knowles MR; Dukes GE
    Pharmacotherapy; 1997; 17(2):263-70. PubMed ID: 9085317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic evaluation of cefsulodin in children with and without cystic fibrosis treated for infectious diseases.
    Michalsen H; Bergan T; Solberg R
    Methods Find Exp Clin Pharmacol; 1986 Nov; 8(11):685-7. PubMed ID: 3807469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adaptation of the oral dosage of theophylline to the asthmatic child. Value of a kinetic test by the intravenous route].
    Albertini M; Lapalus P; Maurin S; Boutte P; Mariani R
    Arch Fr Pediatr; 1982 Nov; 39(9):671-5. PubMed ID: 7165461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of azlocillin in children with and without cystic fibrosis treated for infectious diseases.
    Michalsen H; Bergan T
    Methods Find Exp Clin Pharmacol; 1986 Dec; 8(12):727-9. PubMed ID: 3807473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Theophylline in childhood asthma. Pharmacokinetic and clinical study (author's transl)].
    Bellon G; Plasse JC; Satta S; Barbier Y; Gilly R
    Rev Fr Mal Respir; 1981; 9(2):113-21. PubMed ID: 7255850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum theophylline levels after oral administration in a group of asthmatic children].
    Escorihuela R; Llerena P; Royo F; Lillo Lillo M; de la Morena E; Borges Domingo T; López-Linares M
    An Esp Pediatr; 1982 Dec; 17(6):461-5. PubMed ID: 7183217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K; Weren M; Proesmans M; Kerem E
    Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theophylline disposition in patients with hepatic cirrhosis.
    Piafsky KM; Sitar DS; Rangno RE; Ogilvie RI
    N Engl J Med; 1977 Jun; 296(26):1495-7. PubMed ID: 865528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Chiou method for determining theophylline dosages.
    Johnson MH; Burkle WS
    Clin Pharm; 1984; 3(2):174-8. PubMed ID: 6723223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of pharmacokinetic profile in evaluating patients with repeatedly low theophylline concentrations.
    Georgitis JW; Szefler SJ; Baswell B; Shen DD
    Ann Allergy; 1984 Sep; 53(3):231-5. PubMed ID: 6476482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion from intravenous aminophylline to sustained-release theophylline: computer simulation versus in vivo results.
    Hatton RC; Gotz VP; Robinson JD; Russell WL; Ryerson GG
    Clin Pharm; 1983; 2(4):347-52. PubMed ID: 6883961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced renal excretion of dicloxacillin in patients with cystic fibrosis.
    Jusko WJ; Mosovich LL; Gerbracht LM; Mattar ME; Yaffe SJ
    Pediatrics; 1975 Dec; 56(6):1038-44. PubMed ID: 1196754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The theophylline disposition after caffeine administration in liver cirrhosis: an index of liver function.
    Hartleb M; Romańczyk T; Becker A; Mańczyk I; Waluga M; Spalińska M; Zieliński M
    Ital J Gastroenterol; 1992; 24(6):332-7. PubMed ID: 1515659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.